Compare
Trupanion, Inc. vs Alignment Healthcare, Inc. vs Centene Corp vs Elevance Health, Inc.
| Latest fiscal year | Trupanion, Inc. TRUP | Alignment Healthcare, Inc. ALHC | Centene Corp CNC | Elevance Health, Inc. ELV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.44B | $3.95B | $194.78B | $199.12B |
| Revenue growth (YoY) | +11.9% | +46.1% | +19.4% | +12.5% |
| Gross margin | n/a | n/a | 7.3% | n/a |
| Operating margin | 1.0% | 0.4% | -3.9% | 3.6% |
| Net margin | n/a | 0.0% | -3.4% | 2.8% |
| Net income | n/a | -$724.0K | -$6.67B | $5.66B |
| EPS (Diluted) | $0.45 | $0.00 | -$13.53 | $25.21 |
| Operating cash flow | $89.49M | $139.93M | $5.09B | $4.29B |
| Free cash flow | $75.36M | $113.15M | $4.32B | $3.17B |
| Cash & equivalents | $138.02M | $575.82M | $17.89B | $9.49B |
| Total assets | $915.04M | $1.07B | $76.75B | $121.49B |
| Total liabilities | $531.11M | $886.51M | $56.69B | $77.47B |
| Shareholders' equity | $383.94M | $179.28M | $20.03B | $43.88B |
| Return on year-end equity | n/a | -0.4% | -33.3% | 12.9% |
| Shares outstanding | 43.40M | 204.15M | 491.76M | 220.72M |
Revenue, most recent five fiscal years
| Fiscal year | Trupanion, Inc. | Alignment Healthcare, Inc. | Centene Corp | Elevance Health, Inc. |
|---|---|---|---|---|
| Latest | $1.44B Ended 2025-12-31 | $3.95B Ended 2025-12-31 | $194.78B Ended 2025-12-31 | $199.12B Ended 2025-12-31 |
| 1 year earlier | $1.29B Ended 2024-12-31 | $2.70B Ended 2024-12-31 | $163.07B Ended 2024-12-31 | $177.01B Ended 2024-12-31 |
| 2 years earlier | $1.11B Ended 2023-12-31 | $1.82B Ended 2023-12-31 | $154.00B Ended 2023-12-31 | $171.34B Ended 2023-12-31 |
| 3 years earlier | $905.18M Ended 2022-12-31 | $1.43B Ended 2022-12-31 | $144.55B Ended 2022-12-31 | $156.59B Ended 2022-12-31 |
| 4 years earlier | $698.99M Ended 2021-12-31 | $1.17B Ended 2021-12-31 | $125.98B Ended 2021-12-31 | $138.64B Ended 2021-12-31 |